Table 5
Number of outcome categories improved in
| None (n=16) | 1 Improved (n=65) | 2 Improved (n=47) | 3 Improved (n=8) | ||
|---|---|---|---|---|---|
| Mean age (SD) | 66.4 (16.1) | 64.4 (17.7) | 70.9 (14.5) | 79.0 (2.6) | 0.103 |
| Sex | |||||
| Female | 6 (6.7%) | 46 (51.7%) | 31 (34.8%) | 6 (6.7%) | |
| Male | 10 (21.3%) | 19 (40.4%) | 16 (34.0%) | 2 (4.3%) | 0.083 |
| Diagnosis | |||||
| Corneal degen | 1 (16.7%) | 3 (50.0%) | 2 (33.3%) | ||
| Trauma | 2 (40.0%) | 3 (60.0%) | |||
| Scar/oedema | 7 (70.0%) | 3 (30.0%) | |||
| Fuchs' | 3 (15.8%) | 8 (42.1%) | 7 (36.8%) | 1 (5.3%) | |
| Keratitis | 1 (7.7.%) | 10 (76.9%) | 2 (15.4%) | ||
| Keratoconus | 2 (13.3%) | 10 (66.7%) | 2 (13.3%) | 1 (6.7%) | |
| PBK/ABK | 5 (10.2%) | 20 (40.8%) | 19 (38.8%) | 5 (10.2%) | |
| Regraft | 4 (21.1%) | 5 (26.3%) | 9 (47.4%) | 1 (5.3%) | 0.524 |
| Preop visual acuity (best eye) | |||||
| ≥20/40 | 13 (15.3%) | 44 (53.7%) | 25 (30.5%) | ||
| 20/60–20/80 | 2 (8.0%) | 8 (32.0%) | 12 (48.0%) | 3 (12.0%) | |
| 20/100–20/200 | 10 (41.7%) | 9 (37.5%) | 5 (20.8%) | ||
| <20/200 | 1 (20.0%) | 3 (60.0%) | 1 (20.0%) | 0 (0.0%) | 0.003 |
| Preop pain | |||||
| None | 13 (16.7%) | 51 (65.4%) | 14 (17.9%) | ||
| Intermittent | 2 (4.7%) | 10 (23.3%) | 27 (60.5%) | 5 (11.6%) | |
| Constant | 1 (6.7%) | 4 (26.7%) | 7 (46.7%) | 3 (20.0%) | <0.001 |
| Mean preop VFA (SD) | 74.4 (23.1) | 64.8 (26.1) | 63.9 (20.4) | 48.4 (23.5) | 0.095 |
| Mean priority points | 24.9 (20.5) | 30.1 (20.8) | 42.7 (14.8) | 63.1 (15.6) | <0.001 |
| Mean months waited | 9.2 (11.3) | 8.4 (10.1) | 7.9 (9.5) | 1.9 (1.1) | 0.336 |
| Surgeon | |||||
| A | 1 (6.3%) | 7 (43.8%) | 7 (43.8%) | 1 (6.3%) | |
| B | 5 (12.2%) | 15 (36.6%) | 16 (39.0%) | 5 (12.2%) | |
| C | 4 (13.8%) | 16 (55.2%) | 9 (31.0%) | ||
| D | 1 (8.3%) | 7 (58.3%) | 4 (33.3%) | ||
| E | 2 (10.0%) | 12 (60.0%) | 6 (30.0%) | ||
| F | 3 (14.3%) | 8 (38.1%) | 7 (33.3%) | 3 (14.3%) | 0.644 |
